INO
Inovio Pharmaceuticals Inc
Price:  
7.89 
USD
Volume:  
288,503.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INO WACC - Weighted Average Cost of Capital

The WACC of Inovio Pharmaceuticals Inc (INO) is 8.1%.

The Cost of Equity of Inovio Pharmaceuticals Inc (INO) is 8.40%.
The Cost of Debt of Inovio Pharmaceuticals Inc (INO) is 7.00%.

Range Selected
Cost of equity 7.30% - 9.50% 8.40%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 7.1% - 9.1% 8.1%
WACC

INO WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.68 0.78
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.30% 9.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.12 0.12
Cost of debt 7.00% 7.00%
After-tax WACC 7.1% 9.1%
Selected WACC 8.1%